IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan

(OTC:IRME) IR-MED Ltd., a developer of infrared spectroscopy-based medical device technology, and Dice Technologies Co., Ltd., a Japanese healthcare digital transformation and medical IT provider, announced the signing of a Letter of Intent (LOI). The LOI establishes a framework for cooperation between IR-MED Ltd. and Dice Technologies Co., Ltd. regarding the evaluation, research support, localization, commercialization preparation, and regulatory preparation of IR-MED's PressureSafe™ device for the Japanese market. The LOI includes certain provisions relating to confidentiality. The announcement identifies IR-MED's PressureSafe™ device as the subject of the cooperation. The LOI is not a binding agreement for commercialization but sets forth the intended areas of collaboration. The parties have not disclosed any financial terms, specific timelines, or regulatory milestones in this announcement. The announcement does not specify any executives or provide direct quotations. The release does not mention any payment, fee, or securities compensation related to the LOI. The announcement is focused on the Japanese market and the PressureSafe™ device.